SG Americas Securities
AGN.PRA

SG Americas Securities’s Allergan plc AGN.PRA Stock Holding History

SG Americas Securities’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32,581
Closed -$19.1M – 3739
2017
Q4 		$19.1M Sell
32,581
-33,049
-50% -$21.3M 0.18% 92
2017
Q3 		$48.4M Buy
65,630
+51,071
+351% +$42.4M 0.42% 32
2017
Q2 		$12.6M Sell
14,559
-47,500
-77% -$39.8M 0.11% 175
2017
Q1 		$52.7M Buy
62,059
+46,600
+301% +$38.6M 0.47% 42
2016
Q4 		$11.8M Sell
15,459
-14,000
-48% -$10.6M 0.1% 196
2016
Q3 		$24.2M Sell
29,459
-70,240
-70% -$60.7M 0.25% 67
2016
Q2 		$83.1M Buy
99,699
+30,515
+44% +$25.5M 0.59% 19
2016
Q1 		$63.6M Buy
69,184
+22,908
+50% +$21.9M 0.46% 29
2015
Q4 		$47.7M Buy
46,276
+41,276
+826% +$41.5M 0.34% 44
2015
Q3 		$4.72M Hold
5,000
– – 0.03% 393
2015
Q2 		$5.21M Buy
+5,000
New +$5.23M 0.03% 360

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

SG Americas Securities's AGN.PRA Position: Q1 2018 in Review

SG Americas Securities sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 32,581 shares — an estimated $19.1M sold.

SG Americas Securities first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $83.1M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • SG Americas Securities reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 32,581 Allergan plc shares in Q1 2018, an estimated $19.1M.
  • SG Americas Securities first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • SG Americas Securities's Allergan plc position peaked at $83.1M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.